WaferGen's Q1 Revenues, Loss Rise; Inks Private Placements | GenomeWeb
NEW YORK (GenomeWeb News) – WaferGen today reported that its first-quarter revenues tripled and its net loss nearly doubled for the three-month period ended March 31.
 
The Fremont, Calif.-based firm also announced that it has signed two private placements that could bring in close to $6 million in funding.
 
WaferGen, which makes the SmartChip Real-Time PCR System, brought in Q1 revenues of $181,640, compared to 2007 first-quarter revenues of $60,460.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.